Skip to content
DNDi Logo
  • DNDi JAPAN
  • DNDi LATIN AMERICA
  • DNDi NORTH AMERICA
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Menu
  • ABOUT US
        • ABOUT US
        • BUSINESS MODEL
        • DNDi‘s POLICIES
        • DNDi WORLDWIDE
        • OUR PEOPLE
        • ANNUAL REPORTS
        • E-NEWS
        • JOB OPPORTUNITIES
        • CONTACT US
    • Close
  • DISEASES & PROJECTS
        • DISEASES
          • SLEEPING SICKNESS
          • LEISHMANIASIS
          • CHAGAS DISEASE
          • PAEDIATRIC HIV
          • FILARIAL DISEASE
          • MYCETOMA
          • HEPATITIS C
          • MALARIA
        • PROJECT PORTFOLIO
        • DNDi's Portfolio
        • GLOBAL ANTIBIOTIC R&D PARTNERSHIP (GARDP)
        • TARGET PRODUCT PROFILES
        • CLINICAL TRIALS
        • OPEN INNOVATION PORTAL
    • Close
  • ACHIEVEMENTS
        • DNDi ACHIEVEMENTS
          • ASAQ (Malaria)
          • ASMQ (Malaria)
          • NECT (Sleeping Sickness)
          • PAEDIATRIC BENZNIDAZOLE (Chagas)
          • SSG&PM (Kala azar)
          • NEW VL TREATMENTS – ASIA (Kala azar)
          • SUPERBOOSTER THERAPY (Paediatric HIV/TB)
    • Close
  • STRENGTHENING CAPACITY
        • OVERVIEW
          • LEAP PLATFORM
          • HAT PLATFORM
          • CHAGAS PLATFORM
          • REDELEISH NETWORK
        • TECHNOLOGY TRANSFER ASAQ
        • TECHNOLOGY TRANSFER ASMQ
    • Close
  • ADVOCACY
      • ADVOCACY UPDATES
      • ACCESS
      • INTELLECTUAL PROPERTY
    • Close
  • MEDIA CENTRE
        • OVERVIEW
        • NEWS, VIEWS & STORIES
        • PRESS RELEASES
        • PRESS KIT
        • IN THE MEDIA
        • OUR PUBLICATIONS
        • ANNUAL REPORTS
        • E-NEWS
        • MULTIMEDIA
        • SCIENTIFIC ARTICLES
        • EVENTS
    • Close
  • PARTNERS
      • OVERVIEW
      • BUSINESS MODEL
      • PARTNERS
      • BECOME A DNDi PARTNER
      • RFP
    • Close
  • DONORS
      • DONATE
      • HOW TO HELP
      • DONORS
      • KEY FINANCIAL FIGURES
    • Close
    • Close
  • Home
  • Media Centre

In the Media

IFLScience [12 April 2018]

“Non-profit’s $300 hepatitis C cure rivals current $48,000-plus options”

Click here to read the article

In the MediaHepatitis C, Treatment

The Guardian [12 April 2018]

“Non-profit’s $300 hepatitis C cure as effective as $84,000 alternative”

Click here to read the article

In the MediaHepatitis C, Treatment

Healio [8 April 2018]

“International partnership invests $15.5 million to combat neglected tropical diseases, TB, malaria”

Click here to read the article

In the MediaChagas disease, Drug Discovery, Funding, Leishmaniasis, Malaria, Partnership

The Star Online [20 March 2018]

“NGOs laud ministry’s efforts as a win for public health”

Click here to read the article

In the MediaAccess, Hepatitis C, Partnership, Treatment

Infobae [16 March 2018]

“Hepatitis C: la importancia de un diagnóstico a tiempo para mejorar el tratamiento de una ‘enfermedad olvidada'” – “Hepatitis C: the importance of a timely diagnosis to improve the treatment of a ‘neglected disease'”

Click here to read the article

In the MediaAccess, Hepatitis C, Partnership, Treatment

The Guardian [16 March 2018]

“Who benefits from biomedical science?”

Click here to read the article

In the MediaAdvocacy, Treatment

Drug Discovery News [14 March 2018]

“Working the crowd”

Click here to read the article

In the MediaDrug Discovery, Mycetoma, Partnership, Treatment

Medscape [14 March 2018]

“Terapia combinada mejora la tasa de cura de la leishmaniasis cutánea, según datos preliminares” – “Combination therapy improves cure rate of cutaneous leishmaniasis, according to preliminary data”

Click here to read the article

In the MediaLeishmaniasis, Treatment

Medscape [9 March 2018]

“Anuncian el desarrollo de un tratamiento accesible en Latinoamérica para la hepatitis C” – “Announcing the development of an accessible treatment in Latin America for hepatitis C”

Click here to read the article

In the MediaAccess, Hepatitis C, Partnership, Treatment

Le Quotidien du Médecin [8 March 2018]

“Hépatite C: le sofosbuvir ‘low cost’ du DNDi arrive en Amérique du Sud” – “Hepatitis C: DNDi’s ‘low cost’ sofosbuvir arrives in South America”

Click here to read the article

In the MediaHepatitis C, Partnership, Treatment

ABC Agencia [8 March 2018]

“Reclaman detener transmisión madre-hijo de Chagas para controlar enfermedad” – “They claim to stop Chagas’ mother-child transmission to control the disease”

Click here to read the article

In the MediaChagas disease, Treatment

BioCentury [7 March 2018]

“DNDi, partners aim to bring cheaper HCV combo to Latin America”

Click here to read the article

In the MediaAccess, Hepatitis C, Partnership, Treatment

Agencia EFE [5 March 2018]

“El tratamiento contra hepatitis C será 14 veces más barato en Latinoamérica” – “The treatment against hepatitis C will be 14 times cheaper in Latin America”

Click here to read the article

In the MediaAccess, Hepatitis C, Partnership, Treatment

Sin Chew Daily [3 March 2018]

“马提供可负担C肝疗法．新方案料40万患者受惠” – “Malaysia provides affordable treatment. 400,000 patients benefit from the new program”

Click here to read the article

In the MediaAccess, Hepatitis C, Partnership, Treatment

The Malaysian Times [2 March 2018]

“Health Ministry taking steps to eliminate ‘deadly’ hepatitis C”

Click here to read the article

In the MediaAccess, Hepatitis C, Partnership, Treatment

Sin Chew Daily [2 March 2018]

“卫生总监：与各机构合作‧应对病毒性肝炎” – “Director of Health: Cooperating with agencies in response to viral hepatitis”

Click here to read the article

In the MediaAccess, Hepatitis C, Partnership, Treatment

The Star Online [2 March 2018]

“Hope for hepatitis C patients”

Click here to read the article

In the MediaAccess, Hepatitis C, Partnership, Treatment

Global Health NOW [1 March 2018]

“The road ahead for the most neglected disease”

Click here to read the article

In the MediaMycetoma, Partnership

El País [20 February 2018]

“Chagas, enfermedad silenciosa que aqueja al pueblo tarijeño” – “Chagas, a silent disease that afflicts the people of Tarija”

Click here to read the article

In the MediaChagas disease, Partnership, Treatment

Africa Science Gateway [15 February 2018]

“DNDi and partners in new platform to defeat mycetoma”

Click here to read the article

In the MediaDrug Discovery, Mycetoma, Partnership

Posts navigation

  • ← Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 36
  • Next →

Media Centre

  • Overview
  • News, Views & Stories
    • News
    • Viewpoints
    • Stories
  • Press Releases
    • Press Releases – Other Languages
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
  • Press Kit
  • In the Media
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • Radio
    • Television
  • Our Publications
  • E-news
    • Subscribe to E-news
    • E-news Archive
    • Special Editions Archive
  • Multimedia
    • Multimedia – Podcasts
  • Scientific Articles
    • Human African Trypanosomiasis (Sleeping Sickness)
    • Visceral Leishmaniasis
    • Cutaneous Leishmaniasis
    • Filarial diseases
    • Chagas Disease
    • Malaria
    • Paediatric HIV
    • Neglected Diseases
    • GARDP
  • Events
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003

Press Contact

media@dndi.org

Media Centre Search

Category
Disease
Topic
Year

Recent Articles

  • Caracol Radio: “Minsalud desarrolla acuerdo para garantizar la atención integral de Chagas”
  • Al Quds: “دواء يشفي فيروس “سي” بنسبة %96″
  • Digital Journal: “Affordable hepatitis C treatment close to launch”

About DNDi

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected patients.

Learn More

  • Vision & Mission
  • Business Plan
  • DNDi‘s Model
  • Diseases & Projects
  • Portfolio
  • Treatments
  • Clinical Trials
  • Annual Report
  • Scientific Articles
  • Contact Us

Work with Us

  • Donate
  • Partnership
  • RFP
  • Jobs

DNDi Worldwide

  • DNDi regional offices
  • DNDi Japan のサイトへはこちらから.
  • DNDi Latin America website
  • DNDi North America website
  • GARDP

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
  • Events

Newsletter

Sign up for the E-news newsletter

I want to receive

  • TERMS OF USE
  • PRIVACY POLICY
  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License